{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:59:38Z","timestamp":1790143178763,"version":"4.0.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1007\/s11064-012-0707-3","type":"journal-article","created":{"date-parts":[[2012,1,23]],"date-time":"2012-01-23T07:52:59Z","timestamp":1327305179000},"page":"1057-1062","source":"Crossref","is-referenced-by-count":72,"title":["The Oxidative Stress May be Induced by the Elevated Homocysteine in Schizophrenic Patients"],"prefix":"10.1007","volume":"37","author":[{"given":"Anna","family":"Dietrich-Muszalska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Malinowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"Olas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafal","family":"G\u0142owacki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Bald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Wachowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta","family":"Rabe-Jab\u0142o\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,1,24]]},"reference":[{"key":"707_CR1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0952-3278(96)90143-X","volume":"55","author":"RD Reddy","year":"1996","unstructured":"Reddy RD, Yao JK (1996) Free radical pathology in schizophrenia: a review. Prostaglandins Leukot Essent Fatty Acids 55:33\u201334","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"707_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-9964(98)00030-9","volume":"32","author":"JK Yao","year":"1998","unstructured":"Yao JK, Reddy R, Mcelhinny LG, Van Kammen DP (1998) Reduced status of plasma total antioxidant capacity in schizophrenia. Schizoph Res 32:1\u20138","journal-title":"Schizoph Res"},{"key":"707_CR3","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1080\/09537100500128872","volume":"16","author":"A Dietrich-Muszalska","year":"2005","unstructured":"Dietrich-Muszalska A, Olas B, Rabe-Jablonska J (2005) Oxidative stress in blood platelets from schizophrenic patients. Platelets 16:386\u2013391","journal-title":"Platelets"},{"key":"707_CR4","first-page":"981","volume":"12","author":"HC Li","year":"2006","unstructured":"Li HC, Chen QZ, Ma Y, Zhou JF (2006) Imbalanced free radicals and antioxidant defense systems in schizophrenia: a comparative study. J Zhejian Univ Sci B 12:981\u2013986","journal-title":"J Zhejian Univ Sci B"},{"key":"707_CR5","first-page":"1","volume":"14","author":"A Dietrich-Muszalska","year":"2007","unstructured":"Dietrich-Muszalska A, Olas B (2007) Isoprostanes as indicators of oxidative stress in schizophrenia. World J Biol Psychiatry 14:1\u20136","journal-title":"World J Biol Psychiatry"},{"key":"707_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000202822","volume":"59","author":"A Dietrich-Muszalska","year":"2009","unstructured":"Dietrich-Muszalska A, Olas B, Glowacki R, Bald E (2009) Oxidative\/nitrative modifications of plasma proteins and thiols from patients with schizophrenia. Neuropsychobiology 59:1\u20137","journal-title":"Neuropsychobiology"},{"key":"707_CR7","unstructured":"Dietrich-Muszalska A, Kontek B (2007) Lipid peroxidation in patients with schizophrenia. Current Topics in Biophysics, Abstracts of the XIII Conference of Polish Biophysics Society, B-28"},{"key":"707_CR8","doi-asserted-by":"crossref","first-page":"H2344","DOI":"10.1152\/ajpheart.00432.2007","volume":"293","author":"MA Carluccio","year":"2007","unstructured":"Carluccio MA, Ancora MA, Massaro M, Carluccio M, Scoditti E, Distante A, Storelli C, De Caterina R (2007) Homocysteine induces VCAM-1 gene expression through NF-kappaB and NAD(P)H oxidase activation: protective role of Mediterranean diet polyphenolic antioxidants. Am J Physiol Heart Circ Physiol 293:H2344\u2013H2354","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"707_CR9","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1080\/09537100802308081","volume":"19","author":"B Olas","year":"2008","unstructured":"Olas B, Kedzierska M, Wachowicz B (2008) Comparative studies on homocysteine and its metabolite\u2014homocysteine thiolactone action in blood platelets in vitro. Platelets 19:520\u2013527","journal-title":"Platelets"},{"key":"707_CR10","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"1994","unstructured":"American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Press, Washington","edition":"4"},{"key":"707_CR11","first-page":"22","volume":"59","author":"DV Sheehan","year":"1998","unstructured":"Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59:22\u201333","journal-title":"J Clin Psychiatry"},{"key":"707_CR12","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/cbf.290020310","volume":"2","author":"B Wachowicz","year":"1984","unstructured":"Wachowicz B (1984) Adenine nucleotides in thrombocytes of birds. Cell Biochem Funct 2:167\u2013170","journal-title":"Cell Biochem Funct"},{"key":"707_CR13","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1042\/bj3300795","volume":"330","author":"J Khan","year":"1998","unstructured":"Khan J, Brennan DM, Bradley N, Gao B, Brukdorfer R, Jacobs M (1998) 3-Nitrotyrosine in the proteins of human plasma determined by an Elisa method. Biochem J 330:795\u2013801","journal-title":"Biochem J"},{"key":"707_CR14","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jnutbio.2005.05.010","volume":"17","author":"B Olas","year":"2006","unstructured":"Olas B, Nowak P, Kolodziejczyk J, Ponczek M, Wachowicz B (2006) Protective effects of resveratrol against oxidative\/nitrative modifications of plasma proteins and lipids exposed to peroxynitrite. J Nut Biochem 17:96\u2013102","journal-title":"J Nut Biochem"},{"key":"707_CR15","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0891-5849(97)00104-4","volume":"23","author":"H Buss","year":"1997","unstructured":"Buss H, Chan TP, Sluis KB, Domigan NM, Winterbourn CC (1997) Protein carbonyl measurement by a sensitive ELISA method. Free Rad Biol Med 23:361\u2013366","journal-title":"Free Rad Biol Med"},{"key":"707_CR16","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/0076-6879(90)86141-H","volume":"186","author":"RL Levine","year":"1990","unstructured":"Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, Ahn BW, Shaltiel S, Stadtman ER (1990) Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 186:464\u2013478","journal-title":"Methods Enzymol"},{"key":"707_CR17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0021-9673(00)01064-5","volume":"914","author":"R Glowacki","year":"2001","unstructured":"Glowacki R, W\u00f3jcik K, Bald E (2001) Facile and sensitive method for the determination of mesna in plasma by high-performance liquid chromatography with ultraviolet detection. J Chromatogr 914:29\u201335","journal-title":"J Chromatogr"},{"key":"707_CR18","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.chroma.2003.11.030","volume":"1032","author":"E Bald","year":"2004","unstructured":"Bald E, Chwatko G, Glowacki R, Kusmierek K (2004) Analysis of plasma thiols by high-performance liquid chromatography with ultraviolet detection. J Chromatogr 1032:109\u2013115","journal-title":"J Chromatogr"},{"key":"707_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V90.1.1","volume":"90","author":"A D\u2019Angelo","year":"1997","unstructured":"D\u2019Angelo A, Selhub J (1997) Homocysteine and thrombotic disease. Blood 90:1\u201311","journal-title":"Blood"},{"key":"707_CR20","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/0003-2697(92)90456-H","volume":"200","author":"MA Mansoor","year":"1992","unstructured":"Mansoor MA, Svardal AM, Ueland PM (1992) Determination of the in vivo redox status of cysteine, cysteinylglycine, homocysteine, and glutathione in human plasma. Anal Biochem 200:218\u2013229","journal-title":"Anal Biochem"},{"key":"707_CR21","first-page":"275","volume":"43","author":"S Ramakrishnan","year":"2006","unstructured":"Ramakrishnan S, Sulochana KN, Lakshmi S, Selvi R, Angayarkanni K (2006) Biochemistry of homocysteine in health and diseases. Indian J Biochem Biophys 43:275\u2013283","journal-title":"Indian J Biochem Biophys"},{"key":"707_CR22","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.psychres.2010.04.008","volume":"179","author":"N Bouaziz","year":"2010","unstructured":"Bouaziz N, Ayedi I, Sidhom O, Kallel A, Rafrafi R, Jomaa R, Melki W, Feki M, Kaabechi N, El Hechmi Z (2010) Plasma homocysteine in schizophrenia: determinants and clinical correlations in Tunisian patients free from antipsychotics. Psychiatry Res 179:24\u201329","journal-title":"Psychiatry Res"},{"key":"707_CR23","first-page":"86","volume":"110","author":"VE Golmbet","year":"2010","unstructured":"Golmbet VE, Lebedeva IS, Alfimova MV, Barkhatova AN, Lezheiko TV, Kolesina NIU, Borozdina SA, Abramova LI (2010) Homocysteine-related genes and attention in patients witch schizophrenia and schizoaffective psychosis. Zh Nevrol Psikhiatr Im S S Korsakova 110:86\u201389","journal-title":"Zh Nevrol Psikhiatr Im S S Korsakova"},{"key":"707_CR24","doi-asserted-by":"crossref","first-page":"134","DOI":"10.4306\/pi.2011.8.2.134","volume":"8","author":"TH Kim","year":"2011","unstructured":"Kim TH, Moon SW (2011) Serum homocysteine and folate levels in Korean schizophrenic patients. Psychiatry Invest 8:134\u2013140","journal-title":"Psychiatry Invest"},{"key":"707_CR25","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.pnpbp.2007.05.011","volume":"15","author":"A Haidemenos","year":"2007","unstructured":"Haidemenos A, Kontis D, Kallai E, Allin M, Lucia B (2007) Plasma homocysteine, folate and B12 in chronic schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 15:1289\u20131296","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"707_CR26","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1007\/s007020200097","volume":"109","author":"S Bleich","year":"2002","unstructured":"Bleich S, Junemann A, Von Ahsen N, Lausen B, Ritter K, Beck G, Naumann GO, Kamhuber J (2002) Homocysteine and risk of open-angle glaucoma. J Neural Transm 109:1499\u20131504","journal-title":"J Neural Transm"},{"key":"707_CR27","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1212\/WNL.58.10.1539","volume":"58","author":"PS Sachdev","year":"2002","unstructured":"Sachdev PS, Valenzuela M, Wang XL, Looi JC, Brodaty H (2002) Relationship between plasma homocysteine levels and brain atrophy in healthy elderly individuals. Neurology 58:1539\u20131541","journal-title":"Neurology"},{"key":"707_CR28","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1001\/archpsyc.64.8.980","volume":"64","author":"AS Brown","year":"2007","unstructured":"Brown AS, Bottiglieri T, Schaefer CA, Quesenberry CPJR, Liu L, Bresnahan M, Susser ES (2007) Elevated prenatal homocysteine levels as a risk factor for schizophrenia. Arch Gen Psychiatry 64:980\u2013981","journal-title":"Arch Gen Psychiatry"},{"key":"707_CR29","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.schres.2007.08.004","volume":"97","author":"H Song","year":"2007","unstructured":"Song H, Ueno S, Numata S, Iga J, Shibuya-Tayoshi S, Nakataki M, Tayoshi S, Yamauchi K, Sumitani S, Tomotake T, Tada T, Tanahashi T, Itakura M, Ohmori T (2007) Association between PNPO and schizophrenia in the Japanese population. Schizoph Res 97:264\u2013270","journal-title":"Schizoph Res"},{"key":"707_CR30","doi-asserted-by":"crossref","first-page":"5923","DOI":"10.1073\/pnas.94.11.5923","volume":"94","author":"SA Lipton","year":"1997","unstructured":"Lipton SA, Kim W, Coi Y, Kumar S, D\u2019Emilia DM, Rayadu PV, Arnelle DR, Stamler JS (1997) Neurotoxicity associated with dual actions of homocysteine at the N-methyl-d-aspartate receptor. Proc Natl Acad Sci USA 94:5923\u20135928","journal-title":"Proc Natl Acad Sci USA"},{"key":"707_CR31","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/jnr.10416","volume":"70","author":"PI Ho","year":"2002","unstructured":"Ho PI, Ortiz D, Rogers E, Shea TM (2002) Multiple aspects of homocysteine neurotoxicity: glutamate excitotoxicity, kinsa hyperactivation and DNA damage. J Neurosci Res 70:694\u2013702","journal-title":"J Neurosci Res"},{"key":"707_CR32","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1006\/exer.2001.1009","volume":"73","author":"P Moore","year":"2001","unstructured":"Moore P, El-Sherbeny A, Roon P, Schoenlein PV, Ganapathy V, Smoth SB (2001) Apoptotic cell death in the mouse retinal ganlion cell layer is induced in vivo by the excitatory amino acid homocysteine. Exp Eye Res 73:45\u201357","journal-title":"Exp Eye Res"},{"key":"707_CR33","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00005344-200203000-00005","volume":"39","author":"KR Dimitrova","year":"2002","unstructured":"Dimitrova KR, Degroot KW, Suyderhoud JP, Pirovic EA, Munro TJ, Wieneke J, Myers AK, Kim YD (2002) 17-\u03b2 estradiol preserves endothelial cell viability in an in vitro model of homocysteine-induced oxidative stress. J Cardiovasc Pharmacol 39:347\u2013353","journal-title":"J Cardiovasc Pharmacol"},{"key":"707_CR34","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2165\/00023210-200115040-00004","volume":"15","author":"JK Yao","year":"2001","unstructured":"Yao JK, Reddy R, Mcelhinny LG, Van Kammen DP (2001) Oxidative damage and schizphrenia: an overview of the evidence and its therapeutic implications. CNS Drugs 15:287\u2013310","journal-title":"CNS Drugs"},{"key":"707_CR35","first-page":"215","volume":"4","author":"A Dietrich-Muszalska","year":"2004","unstructured":"Dietrich-Muszalska A (2004) Evaluation of the effects of different concentrations of risperidone, corresponding to the drug doses used in treatment of schizophrenic patients, on lipid peroxidation in plasma and blood platelets at in vitro studies. Psychiatria i Psychologia Kliniczna 4:215\u2013223","journal-title":"Psychiatria i Psychologia Kliniczna"},{"key":"707_CR36","first-page":"18","volume":"1","author":"A Dietrich-Muszalska","year":"2005","unstructured":"Dietrich-Muszalska A (2005) The impact of different concentrations of clozapine on changes of lipid peroxidation in human plasma\u2014in vitro studies. Psychiatria i Psychologia Kliniczna 1:18\u201325","journal-title":"Psychiatria i Psychologia Kliniczna"},{"key":"707_CR37","first-page":"513","volume":"56","author":"E Eren","year":"2010","unstructured":"Eren E, Yegin A, Yilmaz N, Herken H (2010) Serum total homocysteine, folate and vitamin B12 levels and their correlation with antipsychotic drug doses in adult male patients with chronic schizophrenia. Clin Lab 56:513\u2013518","journal-title":"Clin Lab"},{"key":"707_CR38","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1600-0447.2005.00621.x","volume":"113","author":"DC Henderson","year":"2006","unstructured":"Henderson DC, Copeland PM, Nguyen DD, Borba CP, Cather C, Evins AE, Freudenreich O, Baer L, Goff DC (2006) Homocysteine levels and glucose metabolism in non-obese, non-diabetic chronic schizophrenia. Acta Psychiatr Scand 113:121\u2013125","journal-title":"Acta Psychiatr Scand"},{"key":"707_CR39","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1176\/appi.ajp.162.9.1738","volume":"162","author":"G Neeman","year":"2005","unstructured":"Neeman G, Blanaru M, Bloch B, Kremer I, Ermilov M, Javitt DC, Heresco-Levy U (2005) Relation of plasma glycine, serine, and homocysteine levels to schizophrenia symptoms and medication type. Am J Psychiatry 162:1738\u20131740","journal-title":"Am J Psychiatry"},{"key":"707_CR40","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3109\/09537104.2010.550349","volume":"22","author":"J Malinowska","year":"2011","unstructured":"Malinowska J, Olas B (2011) Response of blood platelets to resveratrol during model of hyperhomocysteinemia. Platelets 22:277\u2013283","journal-title":"Platelets"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s11064-012-0707-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T04:59:57Z","timestamp":1593579597000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-012-0707-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,24]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["707"],"URL":"https:\/\/doi.org\/10.1007\/s11064-012-0707-3","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,24]]}}}